CD8+ T cells are able to recognize HER2 peptides represented on MCH class I molecules, trigger apoptosis and cell cycle arrest, as well as eliminate tumor cells by releasing IFN-γ, TNF-α and a number of other cytotoxic cytokines. The gene discussed is ERBB2; the disease is neoplasm.